Enanta Pharmaceuticals (ENTA) Q3 2024 Earnings

5AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-2
-1.69
-1.38
-1.07

Details

Expected EPS
-1.4325
Actual EPS
-1.07
Surprise EPS
0.36
Surprise Percent
+25.31%

Description

Enanta Pharmaceuticals (ENTA) has reported earnings of -1.07 per share for Q3 2024.

0 Comments

Share your thoughts